论文部分内容阅读
目的:探讨老年急性ST段抬高型心肌梗死(STEMI)患者危险因素聚集、再灌注治疗及口服药物治疗方面的特征。方法:回顾性分析2006年1～12月间住院的105例老年(≥60岁)STEMI患者的临床资料,并与同期的77例非老年(<60岁)患者进行比较。结果:老年组高血压患病率(70.48:50.65)、高血压病程(12.88年:8.20年)、糖尿病患病率(40.95:22.08)及HDL-C水平(1.104mmol/L:1.014mmol/L)均明显高于非老年组;吸烟史(51.43:80.52)、吸烟量(21.60支/d:27.80支/d)、冠心病家族史(1.90:12.99)及TG水平(1.380mmol/L:1.862mmol/L)均明显低于非老年组。老年组溶栓(10.48:22.08)、β受体阻滞剂(51.43:72.73)、阿司匹林(67.62:89.61)及氯吡格雷(70.48:87.01)治疗率均明显低于非老年组。结论:与非老年患者相比,老年STEMI患者高血压和糖尿病的患病率更高,冠心病家族史、吸烟及血脂异常情况相对低,溶栓、β受体阻滞剂、阿司匹林及氯吡格雷的治疗率低。
Objective: To investigate the characteristics of elderly patients with acute ST-segment elevation myocardial infarction (STEMI) risk factors aggregation, reperfusion and oral drug treatment. Methods: The clinical data of 105 elderly patients (≥60 years old) with STEMI hospitalized from January 2006 to December 2006 were retrospectively analyzed and compared with 77 non-elderly (<60 years) patients in the same period. Results: The prevalence of hypertension (70.48: 50.65), duration of hypertension (12.88 years: 8.22 years), prevalence of diabetes (40.95: 22.08) and HDL-C (51.43: 80.52), smoking (21.60 / d: 27.80), family history of coronary heart disease (1.90: 12.99) and TG level (1.380mmol / L: 1.862) mmol / L) were significantly lower than non-elderly group. The rates of thrombolysis (10.48: 22.08), β-blockers (51.43: 72.73), aspirin (67.62: 89.61) and clopidogrel (70.48: 87.01) in the elderly group were significantly lower than those in the non-elderly group. Conclusions: The prevalence of hypertension and diabetes is higher in older STEMI patients than in non-elderly patients, with a lower family history of coronary heart disease, smoking and dyslipidemia, thrombolysis, beta-blockers, aspirin, and clopidogrel Gray treatment rate is low.